Author

A. Fassl

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

A. S. Kibel· 1 shared B. Jiang· 1 shared C. Pana· 1 shared F. Gui· 1 shared G. A. Bradshaw· 1 shared J. Jiang· 1 shared J. Koellermann· 1 shared L. Jia· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. S. Kibel

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Acute BRCAness Induction and AR Signaling Blockage through CDK12/7/9 Degradation Enhances PARP Inhibitor Sensitivity in Prostate Cancer

F. Gui, B. Jiang, J. Jiang, Z. He, T. Tsujino, T. Takai, S. Arai, C. Pana, J. Koellermann, G. A. Bradshaw, R. Eisert, M. Kalocsay, A. Fassl, S. P. Balk, A. S. Kibel, L. Jia

This paper introduces BSJ-5-63, a PROTAC that degrades CDK12, CDK7, and CDK9, inducing BRCAness and blocking AR signaling to enhance PARP inhibitor sensitivity in prostate cancer.

bioRxiv · Jul 9, 2024 · PreprintCancer Biology